Markets
local & international
Asia Pacific
Currencies
Commodities
UK
North America
News
latest news
Latest News
Most Viewed
Business
Currencies
Economy
Markets
Property
Technology
Portfolio
analysis & tools
Portfolios
Alerts
Filters
Reports
Watchlists
Help
Products
products & services
Charting
Data Agent
Data Subscriptions
Historical Data
Investment Game
Pricing
Real Edge
Download
Login
Register
Friday, 29 March 2024
Anavex Life Sciences
NASDAQ
AVXL
Summary
|
Chart
|
News
|
History
|
More info..
Recent News
More news...
Anavex 2-73 And The Stabilization Of Alzheimer's Disease
01:45 | 13/3/18
Seeking Alpha
Institutional investment in the company is currently low. The Rett trial has been delayed for unknown reasons. The company will not start a larger Alzheimer's trial until it finishes genomic testing to determine who will respond best to Anavex 2-73 and ...
more»
Premarket analyst action - healthcare
02:18 | 9/3/18
Seeking Alpha
Anavex Life Sciences (NASDAQ:AVXL) initiated with Buy rating and $6 (107% upside) price target at ROTH Capital. Owens & Minor (NYSE:OMI) initiated with Underweight rating and $16 (6% downside risk) price target at Barclays.
more»
Anavex Life Sciences Corp. (AVXL) Settles Into New 52-Week Low on February 26 ...
11:30 | 27/2/18
Equities.com
Shares of Anavex Life Sciences Corp. (AVXL) sank into a new 52-week low yesterday, and could be a company to watch at the open.
more»
Stock in Buy Zone: Anavex Life Sciences Corp. (AVXL)
05:07 | 13/2/18
Street Observer
Anavex Life Sciences Corp. (AVXL) stock price traded with dropping change along with the volume 0.53 million shares on Friday trading session.
more»
Anavex Life Sciences Corp (NASDAQ:AVXL) Facing Numerous Headwinds
00:15 | 10/2/18
Insider Financial
The biopharmaceutical company reported a net loss of (-$4.1) million or (-$0.09) a share compared to a net loss of (-$3.1) million or (-$0.08) reported a year earlier.
more»
Anavex Life Sciences to Present at the 2018 BIO CEO & Investor Conference
01:00 | 9/2/18
GlobeNewswire
NEW YORK, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and ...
more»
Anavex Life Sciences Corp. (AVXL) Plunges 7.02% on February 07
11:30 | 8/2/18
Equities.com
Anavex Life Sciences Corp. (AVXL) had a rough trading day for Wednesday February 07 as shares tumbled 7.02%, or a loss of $-0.2 per share, to close at $2.65.
more»
Anavex Life Sciences to Announce Fiscal First Quarter 2018 Financial Results ...
01:00 | 6/2/18
GlobeNewswire
NEW YORK, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp., (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and ...
more»
Anavex Life Sciences Corp. (AVXL) Plunges 11.47% on January 16
11:30 | 17/1/18
Equities.com
Anavex Life Sciences Corp. (AVXL) had a rough trading day for Tuesday January 16 as shares tumbled 11.47%, or a loss of $-0.39 per share, to close at $3.01.
more»
Anavex Life Sciences Reports Potential Normalization of Hypertension with ...
00:03 | 17/1/18
GlobeNewswire
NEW YORK, Jan. 16, 2018 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and ...
more»
1
2
3
4
5
6
7
8
9
10
11
next»
Global Indices
Code
Last
Change
COMP
10,321
328
3.08%
DJI
29,635
404
1.34%
SP500
3,583
87
2.37%
DAX
12,438
82
0.67%
FTSE
7,488
5
0.07%
NI225
22,420
408
1.86%
TWI
67.27
0.00
0.00%
More news...
No news available...
Currencies
Code
Last
Change
EURUSD
0.9721
0.0055
0.56%
NZDUSD
0.5548
0.0093
1.65%
AUDUSD
0.6194
0.0107
1.70%
NZDAUD
0.8964
0.0010
0.11%